In early June, in addition to participating in the business programme of the St. Petersburg International Economic Forum 2026, representatives of the Health Committee of the Chamber of Representatives of the Congress of the Republic of Colombia will visit Solopharm’s high-tech manufacturing facility – a liquid dosage forms plant in St. Petersburg.
The visit will take place on 3 June as part of the preparations for registering Solopharm’s products in the Colombian pharmaceutical market.
During the visit, the Colombian representatives will become familiar with the company’s production processes, quality control system, modern automated lines, as well as Solopharm’s approaches to ensuring the safety and efficacy of its products.
Solopharm is expanding its international presence and strengthening its position in foreign markets. The company notes that open dialogue with professional and governmental representatives is an important part of building long-term international cooperation.
The delegation’s visit will be an additional step towards developing collaboration between Solopharm and the Colombian healthcare system.
Comment from the Solopharm Press Centre
«For us, it is important not only to develop our export direction but also to foster professional international dialogue based on open interaction and experience exchange. A site visit allows our foreign colleagues to see first-hand how modern pharmaceutical processes are organised, what quality standards are applied at Solopharm’s facilities, and what technological solutions the company uses in its day-to-day operations.»
